CCB
NTUS

Cutter & Co Brokerage’s Natus Medical Inc NTUS Stock Holding History

Cutter & Co Brokerage’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-21,125
Closed -$489K – 280
2020
Q1 		$489K Sell
21,125
-3,750
-15% -$109K 0.18% 110
2019
Q4 		$821K Sell
24,875
-2,800
-10% -$89.7K 0.29% 83
2019
Q3 		$881K Sell
27,675
-3,175
-10% -$92.5K 0.28% 92
2019
Q2 		$793K Sell
30,850
-100
-0.3% -$2.55K 0.25% 97
2019
Q1 		$786K Buy
30,950
+11,675
+61% +$348K 0.22% 97
2018
Q4 		$656K Buy
19,275
+2,325
+14% +$75.6K 0.25% 99
2018
Q3 		$604K Sell
16,950
-125
-0.7% -$4.41K 0.21% 117
2018
Q2 		$589K Sell
17,075
-550
-3% -$19.3K 0.23% 106
2018
Q1 		$593K Buy
+17,625
New +$558K 0.23% 105

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cutter & Co Brokerage's NTUS Position: Q2 2020 in Review

Cutter & Co Brokerage sold out of Natus Medical Inc (NTUS) in Q2 2020, closing a stake of 21,125 shares — an estimated $489K sold.

Cutter & Co Brokerage first reported a position in NTUS in Q1 2018 and held it in 9 quarters. The position peaked at $881K in Q3 2019. 172 funds tracked by Wall St. Rank hold NTUS as of Q2 2020.

  • Cutter & Co Brokerage reported no remaining Natus Medical Inc position as of Q2 2020 after selling out during the quarter.
  • Cutter & Co Brokerage sold 21,125 Natus Medical Inc shares in Q2 2020, an estimated $489K.
  • Cutter & Co Brokerage first reported a position in Natus Medical Inc in Q1 2018 and held it in 9 quarters.
  • Cutter & Co Brokerage's Natus Medical Inc position peaked at $881K in Q3 2019.
  • 172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2020.

Based on Cutter & Co Brokerage's 13F filing for Q2 2020, filed 10 Aug 2020.